{ "run": { "id": "cmnr12sfc02pgp6585rflwztf", "region": "US", "assetId": "cmnr12set02pcp658wes680e3", "ticker": "CHD", "snapshotId": "cmnr12sf002pep658pkslgonc", "promptTemplateId": "cmnqt07si0005lm3jzpxuu1ux", "createdAt": "2026-04-09T05:20:00.357Z", "promptTemplate": { "id": "cmnqt07si0005lm3jzpxuu1ux", "name": "Oficial 08.apr.2026", "version": 1 }, "snapshot": { "id": "cmnr12sf002pep658pkslgonc", "assetId": "cmnr12set02pcp658wes680e3", "asOf": "2026-04-08T20:00:02.000Z", "snapshot": { "asOf": "2026-04-08T20:00:02.000Z", "quote": { "asOf": "2026-04-08T20:00:02.000Z", "open": null, "price": 94.2, "dayLow": 92.465, "volume": 2211369, "dayHigh": 94.31, "currency": "USD", "prevClose": 92.55, "week52Low": 81.33, "week52High": 107.05 }, "fundamentals": { "pe": 27.5822368421053, "beta": 0.211750186882489, "epsTTM": 3.04, "fcfTTM": 1166600000, "growth": { "epsYoy": 0.2719665271966527, "revenueYoy": 0.01573578294116684 }, "sector": "Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics", "margins": { "net": 0.1187774052102141, "gross": 0.447317513541398, "operating": 0.1737167913335053 }, "website": null, "industry": null, "pegRatio": 1.01417763157895, "ebitdaTTM": 1177800000, "forwardPe": 22.1825396825397, "marketCap": 22900000000, "totalCash": 964100000, "totalDebt": 2204600000, "debtEquity": 0.550971965419019, "quickRatio": 1.189224105175165, "revenueTTM": 6203200000, "companyName": "CHURCH & DWIGHT CO INC /DE/", "priceToBook": 5.08480210884014, "currentRatio": 1.702712972110343, "dividendYield": 0.0141127481800722, "returnOnAssets": 0.08294401729126093, "returnOnEquity": 0.184098745689871, "analystOpinions": null, "businessSummary": null, "enterpriseValue": 22146495000, "analystTargetLow": null, "analystTargetHigh": null, "analystTargetMean": null, "fullTimeEmployees": null, "sharesOutstanding": 236694241, "enterpriseToEbitda": 18.80327305145186, "analystTargetMedian": null, "enterpriseToRevenue": 3.570172652824349, "operatingCashflowTTM": 1215400000, "analystRecommendationKey": null } }, "createdAt": "2026-04-09T05:20:00.348Z" }, "results": [ { "id": "cmnr12sfh02pip658qa3qxjcb", "runId": "cmnr12sfc02pgp6585rflwztf", "modelId": "anthropic", "status": "SUCCESS", "rawOutput": "{\"model\":\"ai-equity-research-v1\",\"as_of\":\"2026-04-08T20:00:02.000Z\",\"ticker\":\"CHD\",\"currency\":\"USD\",\"current_price\":94.2,\"target_price_6m\":97.0,\"target_price_12m\":99.5,\"recommendation\":\"HOLD\",\"confidence\":0.62,\"thesis_bullets\":[\"Defensive consumer staples name with low beta of 0.21\",\"Strong EPS growth (+27% YoY) driven by margin expansion\",\"Revenue growth remains anemic at ~1.6% YoY limiting upside\",\"Valuation at 27.6x TTM P/E is premium for modest top-line growth\",\"Solid FCF generation (~$1.17B TTM) supports dividend and buybacks\"],\"key_drivers\":[{\"driver\":\"Gross margin expansion from commodity cost tailwinds\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Sluggish organic revenue growth in core categories\",\"impact\":\"HIGH\",\"direction\":\"NEG\"},{\"driver\":\"Strong free cash flow conversion enabling capital returns\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Private label competition pressuring volume\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Potential bolt-on M&A adding growth verticals\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Consumer trade-down risk in discretionary personal care\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Dividend yield of ~1.4% plus share repurchases\",\"impact\":\"LOW\",\"direction\":\"POS\"},{\"driver\":\"Low beta providing portfolio defensiveness\",\"impact\":\"LOW\",\"direction\":\"POS\"}],\"risks\":[\"Sustained input cost inflation compresses margins back toward historical norms\",\"Aggressive private label expansion erodes branded market share\",\"Tariff escalation on imported raw materials raises COGS\",\"Acquisition integration risk or overpayment for targets\",\"Consumer spending slowdown impacts discretionary product lines\"],\"assumptions\":{\"revenue_cagr_3y\":0.035,\"ebit_margin_target\":0.185,\"wacc\":0.075,\"terminal_multiple\":23.0},\"scenarios\":{\"bear\":{\"target_price\":82.0,\"prob\":0.2,\"notes\":\"Recession drives volume declines and margin compression to 16%.\"},\"base\":{\"target_price\":99.5,\"prob\":0.55,\"notes\":\"Modest organic growth and stable margin expansion to ~18.5%.\"},\"bull\":{\"target_price\":112.0,\"prob\":0.25,\"notes\":\"Accelerating growth via M&A plus margin upside to 19%+.\"}},\"method_notes\":\"Blended valuation: forward P/E (22-24x on ~$4.20 FY+1 EPS) cross-checked with EV/EBITDA (~19x). 12M target of $99.5 implies ~5.6% total return (incl. dividend), consistent with HOLD per rubric given mixed top-line growth vs premium multiple. PEG ~1.0 is fair but not compelling. Scenario-weighted EV ~$98.9 aligns with base. Not investment advice.\"}", "parsedJson": { "as_of": "2026-04-08T20:00:02.000Z", "model": "ai-equity-research-v1", "risks": [ "Sustained input cost inflation compresses margins back toward historical norms", "Aggressive private label expansion erodes branded market share", "Tariff escalation on imported raw materials raises COGS", "Acquisition integration risk or overpayment for targets", "Consumer spending slowdown impacts discretionary product lines" ], "ticker": "CHD", "currency": "USD", "scenarios": { "base": { "prob": 0.55, "notes": "Modest organic growth and stable margin expansion to ~18.5%.", "target_price": 99.5 }, "bear": { "prob": 0.2, "notes": "Recession drives volume declines and margin compression to 16%.", "target_price": 82 }, "bull": { "prob": 0.25, "notes": "Accelerating growth via M&A plus margin upside to 19%+.", "target_price": 112 } }, "confidence": 0.62, "assumptions": { "wacc": 0.075, "revenue_cagr_3y": 0.035, "terminal_multiple": 23, "ebit_margin_target": 0.185 }, "key_drivers": [ { "driver": "Gross margin expansion from commodity cost tailwinds", "impact": "HIGH", "direction": "POS" }, { "driver": "Sluggish organic revenue growth in core categories", "impact": "HIGH", "direction": "NEG" }, { "driver": "Strong free cash flow conversion enabling capital returns", "impact": "MED", "direction": "POS" }, { "driver": "Private label competition pressuring volume", "impact": "MED", "direction": "NEG" }, { "driver": "Potential bolt-on M&A adding growth verticals", "impact": "MED", "direction": "POS" }, { "driver": "Consumer trade-down risk in discretionary personal care", "impact": "MED", "direction": "NEG" }, { "driver": "Dividend yield of ~1.4% plus share repurchases", "impact": "LOW", "direction": "POS" }, { "driver": "Low beta providing portfolio defensiveness", "impact": "LOW", "direction": "POS" } ], "method_notes": "Blended valuation: forward P/E (22-24x on ~$4.20 FY+1 EPS) cross-checked with EV/EBITDA (~19x). 12M target of $99.5 implies ~5.6% total return (incl. dividend), consistent with HOLD per rubric given mixed top-line growth vs premium multiple. PEG ~1.0 is fair but not compelling. Scenario-weighted EV ~$98.9 aligns with base. Not investment advice.", "current_price": 94.2, "recommendation": "HOLD", "thesis_bullets": [ "Defensive consumer staples name with low beta of 0.21", "Strong EPS growth (+27% YoY) driven by margin expansion", "Revenue growth remains anemic at ~1.6% YoY limiting upside", "Valuation at 27.6x TTM P/E is premium for modest top-line growth", "Solid FCF generation (~$1.17B TTM) supports dividend and buybacks" ], "target_price_6m": 97, "target_price_12m": 99.5 }, "errorsJson": { "attempts": [], "providerMeta": { "provider": "anthropic", "webSearch": { "enabled": false, "maxToolCalls": 2, "disabledReason": null }, "pauseTurns": 0, "stopReason": "end_turn" }, "sanityIssues": [] }, "latencyMs": 37878, "createdAt": "2026-04-09T05:20:00.357Z", "usage": { "inputTokens": 3527, "outputTokens": 1834, "costUsd": 0.063485 } }, { "id": "cmnr12sfh02plp658abdgg11i", "runId": "cmnr12sfc02pgp6585rflwztf", "modelId": "deepseek.reasoner", "status": "SUCCESS", "rawOutput": "{\n \"model\": \"AI Equity Research Model\",\n \"as_of\": \"2026-04-08T20:00:02.000Z\",\n \"ticker\": \"CHD\",\n \"currency\": \"USD\",\n \"current_price\": 94.2,\n \"target_price_6m\": 98.0,\n \"target_price_12m\": 103.0,\n \"recommendation\": \"BUY\",\n \"confidence\": 0.65,\n \"thesis_bullets\": [\n \"Defensive stock with low beta and stable cash flows.\",\n \"High operating margins and improving efficiency.\",\n \"Modest revenue growth offset by strong EPS expansion.\",\n \"Current valuation priced for growth, leaving limited upside.\",\n \"Balanced risk-reward with potential for steady returns.\"\n ],\n \"key_drivers\": [\n { \"driver\": \"Revenue Growth\", \"impact\": \"MED\", \"direction\": \"POS\" },\n { \"driver\": \"Operating Margin\", \"impact\": \"HIGH\", \"direction\": \"POS\" },\n { \"driver\": \"Cost Efficiency\", \"impact\": \"MED\", \"direction\": \"POS\" },\n { \"driver\": \"Market Competition\", \"impact\": \"MED\", \"direction\": \"NEG\" },\n { \"driver\": \"Economic Conditions\", \"impact\": \"LOW\", \"direction\": \"NEG\" },\n { \"driver\": \"Debt Management\", \"impact\": \"LOW\", \"direction\": \"POS\" },\n { \"driver\": \"Product Innovation\", \"impact\": \"MED\", \"direction\": \"POS\" },\n { \"driver\": \"Currency Risk\", \"impact\": \"LOW\", \"direction\": \"NEG\" }\n ],\n \"risks\": [\n \"Slowing consumer demand.\",\n \"Increased competition eroding margins.\",\n \"Input cost inflation.\",\n \"Execution risks in growth initiatives.\",\n \"Regulatory changes.\"\n ],\n \"assumptions\": {\n \"revenue_cagr_3y\": 0.025,\n \"ebit_margin_target\": 0.18,\n \"wacc\": 0.065,\n \"terminal_multiple\": 20\n },\n \"scenarios\": {\n \"bear\": { \"target_price\": 89.0, \"prob\": 0.2, \"notes\": \"Lower growth and multiple contraction.\" },\n \"base\": { \"target_price\": 103.0, \"prob\": 0.6, \"notes\": \"Moderate earnings growth and stable multiples.\" },\n \"bull\": { \"target_price\": 117.0, \"prob\": 0.2, \"notes\": \"Strong growth and multiple expansion.\" }\n },\n \"method_notes\": \"Valuation based on DCF with assumed 2.5% revenue CAGR, 18% EBIT margin, 6.5% WACC, 20x terminal multiple. BUY due to ~9% expected upside. Not investment advice.\"\n}", "parsedJson": { "as_of": "2026-04-08T20:00:02.000Z", "model": "AI Equity Research Model", "risks": [ "Slowing consumer demand.", "Increased competition eroding margins.", "Input cost inflation.", "Execution risks in growth initiatives.", "Regulatory changes." ], "ticker": "CHD", "currency": "USD", "scenarios": { "base": { "prob": 0.6, "notes": "Moderate earnings growth and stable multiples.", "target_price": 103 }, "bear": { "prob": 0.2, "notes": "Lower growth and multiple contraction.", "target_price": 89 }, "bull": { "prob": 0.2, "notes": "Strong growth and multiple expansion.", "target_price": 117 } }, "confidence": 0.65, "assumptions": { "wacc": 0.065, "revenue_cagr_3y": 0.025, "terminal_multiple": 20, "ebit_margin_target": 0.18 }, "key_drivers": [ { "driver": "Revenue Growth", "impact": "MED", "direction": "POS" }, { "driver": "Operating Margin", "impact": "HIGH", "direction": "POS" }, { "driver": "Cost Efficiency", "impact": "MED", "direction": "POS" }, { "driver": "Market Competition", "impact": "MED", "direction": "NEG" }, { "driver": "Economic Conditions", "impact": "LOW", "direction": "NEG" }, { "driver": "Debt Management", "impact": "LOW", "direction": "POS" }, { "driver": "Product Innovation", "impact": "MED", "direction": "POS" }, { "driver": "Currency Risk", "impact": "LOW", "direction": "NEG" } ], "method_notes": "Valuation based on DCF with assumed 2.5% revenue CAGR, 18% EBIT margin, 6.5% WACC, 20x terminal multiple. BUY due to ~9% expected upside. Not investment advice.", "current_price": 94.2, "recommendation": "BUY", "thesis_bullets": [ "Defensive stock with low beta and stable cash flows.", "High operating margins and improving efficiency.", "Modest revenue growth offset by strong EPS expansion.", "Current valuation priced for growth, leaving limited upside.", "Balanced risk-reward with potential for steady returns." ], "target_price_6m": 98, "target_price_12m": 103 }, "errorsJson": { "attempts": [], "providerMeta": { "endpoint": "https://api.deepseek.com/v1/chat/completions", "provider": "deepseek", "webSearch": { "enabled": false, "supported": false }, "responseFormat": "json_object" }, "sanityIssues": [] }, "latencyMs": 345, "createdAt": "2026-04-09T05:20:00.357Z", "usage": { "inputTokens": 2046, "outputTokens": 4470, "costUsd": 0.00245 } }, { "id": "cmnr12sfh02pjp658q5tkp5f6", "runId": "cmnr12sfc02pgp6585rflwztf", "modelId": "gemini.3-pro", "status": "SUCCESS", "rawOutput": "{\n \"model\": \"Defensive Staples Valuation Model\",\n \"as_of\": \"2026-04-08T20:00:02.000Z\",\n \"ticker\": \"CHD\",\n \"currency\": \"USD\",\n \"current_price\": 94.2,\n \"target_price_6m\": 98.0,\n \"target_price_12m\": 102.0,\n \"recommendation\": \"BUY\",\n \"confidence\": 0.75,\n \"thesis_bullets\": [\n \"Defensive portfolio anchored by Arm & Hammer provides resilience in uncertain macroeconomic environments.\",\n \"Strong FCF yield of roughly 5% supports consistent dividend growth and strategic acquisitions.\",\n \"EPS growth outpaces sluggish revenue due to effective cost controls and gross margin expansion.\",\n \"Premium valuation of 22x forward P/E is justified by low beta and earnings stability.\",\n \"Vulnerable to private label trade-down if consumer spending weakens further in household categories.\"\n ],\n \"key_drivers\": [\n {\n \"driver\": \"Volume growth recovery\",\n \"impact\": \"HIGH\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Private label market share gains\",\n \"impact\": \"HIGH\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Gross margin expansion\",\n \"impact\": \"HIGH\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Input cost inflation\",\n \"impact\": \"MED\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"M&A execution and integration\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Marketing spend efficiency\",\n \"impact\": \"LOW\",\n \"direction\": \"POS\"\n }\n ],\n \"risks\": [\n \"Increased competition from private label brands in household and personal care products.\",\n \"Failure to successfully integrate future acquisitions or overpaying for targets.\",\n \"Supply chain disruptions or unexpected spikes in raw material and packaging costs.\",\n \"Over-reliance on the Arm & Hammer mega-brand for enterprise growth and stability.\"\n ],\n \"assumptions\": {\n \"revenue_cagr_3y\": 0.03,\n \"ebit_margin_target\": 0.185,\n \"wacc\": 0.065,\n \"terminal_multiple\": 22.0\n },\n \"scenarios\": {\n \"bear\": {\n \"target_price\": 82.0,\n \"prob\": 0.2,\n \"notes\": \"Consumer trade-down accelerates, compressing margins and driving P/E multiple contraction to 19x.\"\n },\n \"base\": {\n \"target_price\": 102.0,\n \"prob\": 0.6,\n \"notes\": \"Steady margin expansion and low-single-digit volume growth support a 24x forward P/E.\"\n },\n \"bull\": {\n \"target_price\": 112.0,\n \"prob\": 0.2,\n \"notes\": \"Strong volume recovery and successful new product launches drive multiple expansion to 26x.\"\n }\n },\n \"method_notes\": \"Valuation based on a blend of 24x forward P/E and DCF (6.5% WACC, 3% terminal growth). The 12M target implies ~8% upside, supporting a BUY rating given the highly defensive nature of the cash flows. This is not investment advice.\"\n}", "parsedJson": { "as_of": "2026-04-08T20:00:02.000Z", "model": "Defensive Staples Valuation Model", "risks": [ "Increased competition from private label brands in household and personal care products.", "Failure to successfully integrate future acquisitions or overpaying for targets.", "Supply chain disruptions or unexpected spikes in raw material and packaging costs.", "Over-reliance on the Arm & Hammer mega-brand for enterprise growth and stability." ], "ticker": "CHD", "currency": "USD", "scenarios": { "base": { "prob": 0.6, "notes": "Steady margin expansion and low-single-digit volume growth support a 24x forward P/E.", "target_price": 102 }, "bear": { "prob": 0.2, "notes": "Consumer trade-down accelerates, compressing margins and driving P/E multiple contraction to 19x.", "target_price": 82 }, "bull": { "prob": 0.2, "notes": "Strong volume recovery and successful new product launches drive multiple expansion to 26x.", "target_price": 112 } }, "confidence": 0.75, "assumptions": { "wacc": 0.065, "revenue_cagr_3y": 0.03, "terminal_multiple": 22, "ebit_margin_target": 0.185 }, "key_drivers": [ { "driver": "Volume growth recovery", "impact": "HIGH", "direction": "POS" }, { "driver": "Private label market share gains", "impact": "HIGH", "direction": "NEG" }, { "driver": "Gross margin expansion", "impact": "HIGH", "direction": "POS" }, { "driver": "Input cost inflation", "impact": "MED", "direction": "NEG" }, { "driver": "M&A execution and integration", "impact": "MED", "direction": "POS" }, { "driver": "Marketing spend efficiency", "impact": "LOW", "direction": "POS" } ], "method_notes": "Valuation based on a blend of 24x forward P/E and DCF (6.5% WACC, 3% terminal growth). The 12M target implies ~8% upside, supporting a BUY rating given the highly defensive nature of the cash flows. This is not investment advice.", "current_price": 94.2, "recommendation": "BUY", "thesis_bullets": [ "Defensive portfolio anchored by Arm & Hammer provides resilience in uncertain macroeconomic environments.", "Strong FCF yield of roughly 5% supports consistent dividend growth and strategic acquisitions.", "EPS growth outpaces sluggish revenue due to effective cost controls and gross margin expansion.", "Premium valuation of 22x forward P/E is justified by low beta and earnings stability.", "Vulnerable to private label trade-down if consumer spending weakens further in household categories." ], "target_price_6m": 98, "target_price_12m": 102 }, "errorsJson": { "attempts": [], "providerMeta": { "model": "gemini-3-pro-preview", "provider": "gemini", "webSearch": { "used": false, "allowed": false, "enabled": false, "requested": false, "disabledReason": null } }, "sanityIssues": [] }, "latencyMs": 25504, "createdAt": "2026-04-09T05:20:00.357Z", "usage": { "inputTokens": 2392, "outputTokens": 854, "costUsd": 0.015032 } }, { "id": "cmnr12sfh02php658jv7g93m4", "runId": "cmnr12sfc02pgp6585rflwztf", "modelId": "openai.gpt-5.4", "status": "SUCCESS", "rawOutput": "{\"model\":\"OpenAI o3\",\"as_of\":\"2026-04-08T20:00:02.000Z\",\"ticker\":\"CHD\",\"currency\":\"USD\",\"current_price\":94.2,\"target_price_6m\":97.5,\"target_price_12m\":101,\"recommendation\":\"BUY\",\"confidence\":0.61,\"thesis_bullets\":[\"Arm & Hammer portfolio supports resilient volumes and selective pricing power.\",\"Productivity and mix should lift margins despite still-uncertain commodity costs.\",\"Strong cash generation and modest leverage support dividends and bolt-on acquisitions.\",\"Revenue growth remains low, so valuation upside depends more on execution than expansion.\",\"Shares trade at a premium defensive multiple, capping upside if growth disappoints.\"],\"key_drivers\":[{\"driver\":\"Brand pricing power\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Productivity savings\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Mix/premiumization\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Bolt-on M&A execution\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Commodity inflation\",\"impact\":\"HIGH\",\"direction\":\"NEG\"},{\"driver\":\"Private-label competition\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Retailer destocking\",\"impact\":\"LOW\",\"direction\":\"NEG\"},{\"driver\":\"Multiple compression risk\",\"impact\":\"HIGH\",\"direction\":\"NEG\"}],\"risks\":[\"Commodity inflation outpaces pricing.\",\"Private-label share gains pressure volumes.\",\"Acquisition integration underdelivers.\",\"Rates stay higher and compress staples multiples.\",\"International and FX trends weaken growth.\"],\"assumptions\":{\"revenue_cagr_3y\":0.045,\"ebit_margin_target\":0.19,\"wacc\":0.07,\"terminal_multiple\":22.5},\"scenarios\":{\"bear\":{\"target_price\":86,\"prob\":0.25,\"notes\":\"Input costs stay elevated and the defensive premium compresses.\"},\"base\":{\"target_price\":101,\"prob\":0.5,\"notes\":\"Low-single-digit sales growth with modest margin expansion supports fair rerating.\"},\"bull\":{\"target_price\":112,\"prob\":0.25,\"notes\":\"Execution and mix improve faster, sustaining premium valuation.\"}},\"method_notes\":\"Snapshot quote/fundamentals were kept authoritative. Target uses a conservative forward earnings/FCF sanity check with 4.5% sales CAGR, 19.0% EBIT margin, 7.0% WACC, and 22.5x terminal multiple; no sell-side targets used. Base case implies ~7% 12M upside, supporting BUY. not investment advice\"}", "parsedJson": { "as_of": "2026-04-08T20:00:02.000Z", "model": "OpenAI o3", "risks": [ "Commodity inflation outpaces pricing.", "Private-label share gains pressure volumes.", "Acquisition integration underdelivers.", "Rates stay higher and compress staples multiples.", "International and FX trends weaken growth." ], "ticker": "CHD", "currency": "USD", "scenarios": { "base": { "prob": 0.5, "notes": "Low-single-digit sales growth with modest margin expansion supports fair rerating.", "target_price": 101 }, "bear": { "prob": 0.25, "notes": "Input costs stay elevated and the defensive premium compresses.", "target_price": 86 }, "bull": { "prob": 0.25, "notes": "Execution and mix improve faster, sustaining premium valuation.", "target_price": 112 } }, "confidence": 0.61, "assumptions": { "wacc": 0.07, "revenue_cagr_3y": 0.045, "terminal_multiple": 22.5, "ebit_margin_target": 0.19 }, "key_drivers": [ { "driver": "Brand pricing power", "impact": "HIGH", "direction": "POS" }, { "driver": "Productivity savings", "impact": "HIGH", "direction": "POS" }, { "driver": "Mix/premiumization", "impact": "MED", "direction": "POS" }, { "driver": "Bolt-on M&A execution", "impact": "MED", "direction": "POS" }, { "driver": "Commodity inflation", "impact": "HIGH", "direction": "NEG" }, { "driver": "Private-label competition", "impact": "MED", "direction": "NEG" }, { "driver": "Retailer destocking", "impact": "LOW", "direction": "NEG" }, { "driver": "Multiple compression risk", "impact": "HIGH", "direction": "NEG" } ], "method_notes": "Snapshot quote/fundamentals were kept authoritative. Target uses a conservative forward earnings/FCF sanity check with 4.5% sales CAGR, 19.0% EBIT margin, 7.0% WACC, and 22.5x terminal multiple; no sell-side targets used. Base case implies ~7% 12M upside, supporting BUY. not investment advice", "current_price": 94.2, "recommendation": "BUY", "thesis_bullets": [ "Arm & Hammer portfolio supports resilient volumes and selective pricing power.", "Productivity and mix should lift margins despite still-uncertain commodity costs.", "Strong cash generation and modest leverage support dividends and bolt-on acquisitions.", "Revenue growth remains low, so valuation upside depends more on execution than expansion.", "Shares trade at a premium defensive multiple, capping upside if growth disappoints." ], "target_price_6m": 97.5, "target_price_12m": 101 }, "errorsJson": { "attempts": [], "providerMeta": { "provider": "openai", "webSearch": { "used": false, "enabled": false, "sources": [], "maxToolCalls": 2 }, "responseId": "resp_035e4f6790d94d9c0069d7571514848190a372252d3492ee24", "reasoningEffort": "medium", "structuredOutputs": { "used": true, "requested": true, "disabledReason": null } }, "sanityIssues": [] }, "latencyMs": 36375, "createdAt": "2026-04-09T05:20:00.357Z", "usage": { "inputTokens": 2314, "outputTokens": 2085, "costUsd": 0.033239 } }, { "id": "cmnr12sfh02pkp6585g1y0i14", "runId": "cmnr12sfc02pgp6585rflwztf", "modelId": "xai.grok-4.20-reasoning", "status": "SUCCESS", "rawOutput": "{\n \"model\": \"AI Equity Valuation Model\",\n \"as_of\": \"2026-04-08T20:00:02.000Z\",\n \"ticker\": \"CHD\",\n \"currency\": \"USD\",\n \"current_price\": 94.2,\n \"target_price_6m\": 96.5,\n \"target_price_12m\": 99.0,\n \"recommendation\": \"HOLD\",\n \"confidence\": 0.62,\n \"thesis_bullets\": [\n \"Stable staples demand but slow 1.6% revenue growth\",\n \"Strong brands and 27% EPS growth via efficiencies\",\n \"Forward P/E of 22x above sector norms\",\n \"Margin resilience offset by competitive pressures\",\n \"Fair valuation supports limited upside at current levels\"\n ],\n \"key_drivers\": [\n {\n \"driver\": \"Organic revenue growth\",\n \"impact\": \"HIGH\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Brand portfolio strength\",\n \"impact\": \"HIGH\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Operating margin trends\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Input cost inflation\",\n \"impact\": \"MED\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Valuation de-rating risk\",\n \"impact\": \"HIGH\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"M&A execution\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Dividend consistency\",\n \"impact\": \"LOW\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Innovation pipeline\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n }\n ],\n \"risks\": [\n \"Private label competition erosion\",\n \"Commodity cost volatility\",\n \"Acquisition integration failures\",\n \"Regulatory scrutiny on claims\"\n ],\n \"assumptions\": {\n \"revenue_cagr_3y\": 0.03,\n \"ebit_margin_target\": 0.18,\n \"wacc\": 0.07,\n \"terminal_multiple\": 20\n },\n \"scenarios\": {\n \"bear\": {\n \"target_price\": 78,\n \"prob\": 0.3,\n \"notes\": \"Prolonged low growth triggers multiple contraction.\"\n },\n \"base\": {\n \"target_price\": 99,\n \"prob\": 0.5,\n \"notes\": \"Steady execution with stable margins and 3% CAGR.\"\n },\n \"bull\": {\n \"target_price\": 118,\n \"prob\": 0.2,\n \"notes\": \"Accelerated innovation and successful M&A.\"\n }\n },\n \"method_notes\": \"DCF valuation anchored to 3% revenue CAGR, 18% EBIT margin, 7% WACC, 20x terminal. Limited 5% upside at current levels justifies HOLD. Consensus noted but not used in targets. not investment advice.\"\n}", "parsedJson": { "as_of": "2026-04-08T20:00:02.000Z", "model": "AI Equity Valuation Model", "risks": [ "Private label competition erosion", "Commodity cost volatility", "Acquisition integration failures", "Regulatory scrutiny on claims" ], "ticker": "CHD", "currency": "USD", "scenarios": { "base": { "prob": 0.5, "notes": "Steady execution with stable margins and 3% CAGR.", "target_price": 99 }, "bear": { "prob": 0.3, "notes": "Prolonged low growth triggers multiple contraction.", "target_price": 78 }, "bull": { "prob": 0.2, "notes": "Accelerated innovation and successful M&A.", "target_price": 118 } }, "confidence": 0.62, "assumptions": { "wacc": 0.07, "revenue_cagr_3y": 0.03, "terminal_multiple": 20, "ebit_margin_target": 0.18 }, "key_drivers": [ { "driver": "Organic revenue growth", "impact": "HIGH", "direction": "NEG" }, { "driver": "Brand portfolio strength", "impact": "HIGH", "direction": "POS" }, { "driver": "Operating margin trends", "impact": "MED", "direction": "POS" }, { "driver": "Input cost inflation", "impact": "MED", "direction": "NEG" }, { "driver": "Valuation de-rating risk", "impact": "HIGH", "direction": "NEG" }, { "driver": "M&A execution", "impact": "MED", "direction": "POS" }, { "driver": "Dividend consistency", "impact": "LOW", "direction": "POS" }, { "driver": "Innovation pipeline", "impact": "MED", "direction": "POS" } ], "method_notes": "DCF valuation anchored to 3% revenue CAGR, 18% EBIT margin, 7% WACC, 20x terminal. Limited 5% upside at current levels justifies HOLD. Consensus noted but not used in targets. not investment advice.", "current_price": 94.2, "recommendation": "HOLD", "thesis_bullets": [ "Stable staples demand but slow 1.6% revenue growth", "Strong brands and 27% EPS growth via efficiencies", "Forward P/E of 22x above sector norms", "Margin resilience offset by competitive pressures", "Fair valuation supports limited upside at current levels" ], "target_price_6m": 96.5, "target_price_12m": 99 }, "errorsJson": { "attempts": [], "providerMeta": { "provider": "xai", "webSearch": { "used": false, "enabled": false, "sources": [], "maxToolCalls": 2 }, "responseId": "1cb62ad0-0510-956a-a368-371648b7369d", "usedFallbackChatCompletions": false }, "sanityIssues": [] }, "latencyMs": 14179, "createdAt": "2026-04-09T05:20:00.357Z", "usage": { "inputTokens": 2653, "outputTokens": 2910, "costUsd": 0.051609 } } ] } }